SERUM LIPID AND TRACE MINERAL PROFILES AMONG TYPE 2 DIABETICS AND HYPERTENSIVE DIABETICS AT THE BAMENDA REGIONAL HOSPITAL
Objective: Diabetes mellitus has become a clinical condition of public health importance, especially in developing countries due to its high mortality and morbidity. The aim of this study was to measure and compare the lipid and serum trace mineral profile among type 2 diabetics and hypertensive diabetics with controls.
Methods: This cross-sectional study was carried out at the Regional Hospital, Bamenda, involving 50 diabetic normotensives, 50 hypertensive diabetics, and 50 normal recruited subjects. Serum levels of lipids and minerals were determined using standard methods.
Results: Of the four trace elements assessed, except for copper (Cu) whose mean values in diabetics were abnormally increased (p=0.01), zinc (Zn), magnesium (Mg), and chromium (Cr) showed significantly decreased mean values in diabetics compared to the controls (p<0.05). The mean levels of these trace elements were also significantly reduced in hypertensive diabetic patients (p<0.05). In diabetics, there was no significant difference in the lipid levels. However, only total cholesterol (TC) and low-density lipoprotein mean values were significantly higher in hypertensive diabetic patients compared to the normal controls. There was also a positive significant correlation between the body mass index and Cr (r=+0.3, p=0.045) in diabetics.
Conclusion: This study saw statistically significant differences in the serum lipid and trace element levels between diabetics, hypertensive diabetics, and controls: With diabetic and diabetic hypertensive patients having higher serum Cu levels and decreased serum Mg, Zn, and Cr levels compared to the normal controls. The lipid profile levels in diabetics and hypertensive diabetics were not significant differences within the study groups for all lipid profile estimations except for TC and LDL which were significantly higher only in hypertensive diabetic patients.
2. Scoppola A, Montecchi FR, Menzinger G, Lala A. Urinary mevalonate excretion rate in Type 2 diabetes: Role of metabolic control. Atherosclerosis 2001;156:357-61.
3. Tierney LM, Phee MC, Papadakis SJ. Diabetics. In: Current Medical Diagnosis and Treatment. 48th ed. New York: Lange Medical Books/ McGraw-Hill; 2002. p. 120.
4. Rother KI. Diabetes treatment – bridging the divide. N Engl J Med 2007;356:1499-501.
5. Naway LM. Lipid Profile in Sudanese Diabetic Patients. Thesis; 2011.
6. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13:153-69.
7. Aduba O, Onwuamaeze I, Oli J, Udeozo K. Serum cholesterol and high density lipoprotein cholesterol in Nigerian diabetics. East Afr Med J 1984;61:35-9.
8. Adedeji OO, Onitiri AC. Plasma lipids in Nigerian hypertensives. Afr J Med Med Sci 1990;19:281-4.
9. Anaja HP, Isah HS, Abdu-Aguye I, Obura NA. Lipid profiles in diabetic Nigerians: A Zaria update. Int Diabet Dig 1995;6:90-3.
10. Isezuo AS, Badung SL. Plasma lipids among Northwestern Nigerian hypertensives. Sahel Med J 2001;4:181-6.
11. Nourmohammadi I, Shalmani IK, Shaabani M, Gohari L. Zinc, copper, chromium, manganese and magnesium levels in serum and hair of insulin independent diabetics. Arch Iran Med 2000;2:88-91.
12. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997;349:1436 42.
13. Vincent JB. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev 2000;58:67-72.
14. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998;17:109 15.
15. Suarez Z. Decreased insulin sensitivity in skeletal muscle of hypomagnesaemia rats. Diabetologia 1993;36:82.
16. Burtis AC, Ashwood RE. Trace elements. In: Tietz Fundamentals of Clincal Chemistry. 5th ed. India: Saunders; 2003. p. 570-5.
17. Mertz W. Chromium in human nutrition: A review. J Nutr 1993;123:626 33.
18. Martin AC. Calcium, phosphate and magnesium. In: Clinical Chemistry and Metabolic Medicine. 7th ed. London: Hodder Arnold; 2006. p. 113.
19. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH, et al. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension 1991;17:951-7.
20. Yuen VG, McNeill JH. Comparison of the glucose oxidase method for glucose determination by manual assay and automated analyzer. J Pharmacol Toxicol Methods 2000;44:543-6.
21. Altekin E, Coker C, Si?man AR, Onvural B, Kuralay F, Kirimli O, et al. The relationship between trace elements and cardiac markers in acute coronary syndromes. J Trace Elem Med Biol 2005;18:235-42.
22. Lowe J, Taveira-da-Silva R, Hilário-Souza E. Dissecting copper homeostasis in diabetes mellitus. IUBMB Life 2017;69:255-62.
23. Qiu Q, Zhang F, Zhu W, Wu J, Liang M. Copper in diabetes mellitus: A meta-analysis and systematic review of plasma and serum studies. Biol Trace Elem Res 2017;177:53-63.
24. Edan HH. Serum copper level in non insulin diabetes mellitus. Mustansiriya Med J 2006;6:36-41.
25. Abou-Seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004;346:161-70.
26. Chen MD, Lin PY, Tsou CT, Wang JJ, Lin WH. Selected metals status in patients with noninsulin-dependent diabetes mellitus. Biol Trace Elem Res 1995;50:119-24.
27. Rohn RD, Pleban P, Jenkins LL. Magnesium, zinc and copper in plasma and blood cellular components in children with IDDM. Clin Chim Acta 1993;215:21-8.
28. Leonhardt W, Hanefeld M, Müller G, Hora C, Meissner D, Lattke P, et al. Impact of concentrations of glycated hemoglobin, alpha-tocopherol, copper, and manganese on oxidation of low-density lipoproteins in patients with Type I diabetes, Type II diabetes and control subjects. Clin Chim Acta 1996;254:173-86.
29. Wu J, Xun P, Tang Q, Cai W, He K. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and Type 2 diabetes mellitus: A meta-analysis of prospective cohort studies. Nutr J 2017;16:60.
30. Lin CC, Huang YL. Chromium, zinc and magnesium status in Type 1 diabetes. Curr Opin Clin Nutr Metab Care 2015;18:588-92.
31. Veronese N, Watutantrige-Fernando S, Luchini C, Solmi M, Sartore G, Sergi G, et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: A systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr 2016;70:1354-9.
32. Chen S, Jin X, Liu J, Sun T, Xie M, Bao W, et al. Association of plasma magnesium with prediabetes and Type 2 diabetes mellitus in adults. Sci Rep 2017;7:12763.
33. Odusan OO, Familoni OB, Odewabi AO, Idowu AO, Adekolade AS. Patterns and correlates of serum magnesium levels in subsets of Type 2 diabetes mellitus patients in Nigeria. Indian J Endocrinol Metab 2017;21:439-42.
34. Pokharel DR, Khadka D, Sigdel M, Yadav NK, Kafle R, Sapkota RM, et al. Association of serum magnesium level with poor glycemic control and renal functions in Nepalese patients with Type 2 diabetes mellitus. Diabetes Metab Syndr 2017;11 Suppl 1:S417-23.
35. Djurhuus MS, Skøtt P, Vaag A, Hother-Nielsen O, Andersen P, Parving HH, et al. Hyperglycaemia enhances renal magnesium excretion in Type 1 diabetic patients. Scand J Clin Lab Invest 2000;60:403-9.
36. Matsunobu S, Terashima Y, Senshu T, Sano H, Itoh H. Insulin secretion and glucose uptake in hypomagnesemic sheep fed a low magnesium, high potassium diet. J Nutr Biochem 1990;1:167-71.
37. Rodríguez-Morán M, Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res Rev 2011;27:590-6.
38. Eshak ES, Iso H, Maruyama K, Muraki I, Tamakoshi A. Associations between dietary intakes of iron, copper and zinc with risk of Type 2 diabetes mellitus: A large population-based prospective cohort study. Clin Nutr 2018;37:667-74.
39. Viktorínová A, Toserová E, Krizko M, Duracková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009;58:1477-82.
40. Kruse-Jarres JD, Rükgauer M. Trace elements in diabetes mellitus. Peculiarities and clinical validity of determinations in blood cells. J Trace Elem Med Biol 2000;14:21-7.
41. Lin CC, Tsweng GJ, Lee CF, Chen BH, Huang YL. Magnesium, zinc, and chromium levels in children, adolescents, and young adults with Type 1 diabetes. Clin Nutr 2016;35:880-4.
42. Doddigarla Z, Parwez I, Ahmad J. Correlation of serum chromium, zinc, magnesium and SOD levels with hbA1c in Type 2 diabetes: A cross sectional analysis. Diabetes Metab Syndr 2016;10:S126-9.
43. Wang ZQ, Cefalu WT. Current concepts about chromium supplementation in Type 2 diabetes and insulin resistance. Curr Diab Rep 2010;10:145-51.
44. Douglas HC. Nutritional influences on oestrogen metabolism. Fem Res J 2004;4:20-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.